Долгосрочный прогноз у пациентов с церебро-венозным тромбозом - анемия была обнаружена у 1/3 пациентов. Тяжелая или микроцитарная анемия ассоциировалась с самым высоким риском смертности ~10х:
A total of 238 CVT patients were included, among whom 73 patients (30.7%) were diagnosed with anemia.
Subgroup analysis showed that severe anemia was independently associated with mRS of 3-6 (OR = 8.8; 95% CI, 1.9-40.8; P = 0.005) and mortality (OR = 9.8; 95% CI, 1.8-53.3; P = 0.01).
Similarly, microcytic anemia increased the risk of mRS of 3-6 (OR = 4.6; 95% CI, 1.5-14.5; P = 0.008) and mortality (OR = 9.7; 95% CI, 2.6-35.9; P = 0.001).
---
Neurocrit Care. 2018 Jul 9.
Long-Term Outcomes in Patients with Anemia And Cerebral Venous Thrombosis.
Liu K, и соавт.
__________________
Искренне,
Вадим Валерьевич.
|